Skip to content

Author

Yoshiya Tanaka

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus.

OBJECTIVE We compared demographic and clinical characteristics between patients with late-onset (LO) and early-onset (EO) systemic lupus erythematosus (SLE) and examined their longitudinal associations with treatment targets and long-term outcomes, irreversible organ damage accrual and health-related quality of life (H...

W. Louthrenoo, A. Hoi, V. Golder et al. · 0 citations
Open access Oct 2026

Clinical characteristics and severity classification in Mixed Connective Tissue Disease: a nationwide retrospective study.

OBJECTIVES To characterize clinical manifestations, major organ involvement, real-world treatment patterns, and factors associated with severity classification in Japanese patients with mixed connective tissue disease (MCTD), aiming to clarify its heterogeneous clinical spectrum. METHODS This nationwide retrospective...

S. Kubo, Yurie Kanda, Hideto Kameda et al. · 0 citations
Review Open access Aug 2026

Emerging treatment strategies in systemic lupus erythematosus: integrating molecular stratification, targeted therapy, and treatment response evaluation

This review summarizes advances in SLE stratification based on immune phenotyping and multi-omics approaches and outlines emerging therapies, including biologics, intracellular inhibitors, and cell-based treatments.

Yurie Satoh-Kanda, S. Nakayamada, Yoshiya Tanaka · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.